Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 4/2018

03.02.2018

Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study

verfasst von: Siavash Piran, Hugh Traquair, Noel Chan, Marlene Robinson, Sam Schulman

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Anticoagulant-related nephropathy is an acute kidney injury (AKI) associated with excessive anticoagulation. The nature of the association between excessive anticoagulation with warfarin and AKI and its incidence remain unclear. To evaluate the incidence of AKI in excessively anticoagulated patients taking warfarin and examine potential risk factors. A retrospective chart review was performed in patients on chronic warfarin. The primary outcome was AKI, defined as an acute increase in creatinine of > 26.5 µmol/L within 7–14 days of an international normalized ratio (INR) ≥ 4.0. 292 patients with an INR ≥ 4.0 were included. 101 patients had CKD and 191 did not have CKD. Of the 292 patients with an INR ≥ 4.0, 38 (13%) had an AKI. In univariable analyses, CKD [odds ratio (OR) 2.1, 95% confidence interval (CI) 0.99–4.43] and use of renin–angiotensin system (RAS) blockers and/or diuretics (OR 3.85; 95% CI 1.15–20.15) were significantly associated with the risk of AKI. In a binomial logistic regression model, use of RAS blockers and/or diuretics was the only significant predictor of AKI (OR 3.4; 95% CI 1.02–11.76). Use of RAS blockers and/or diuretics significantly increased the risk of AKI in patients with warfarin-related excessive anticoagulation. Further prospective studies examining the association of high INRs and AKI are needed.
Literatur
1.
Zurück zum Zitat Wheeler DS, Giugliano RP, Rangaswami J (2016) Anticoagulation-related nephropathy. J Thromb Haemost 14(3):461–467CrossRefPubMed Wheeler DS, Giugliano RP, Rangaswami J (2016) Anticoagulation-related nephropathy. J Thromb Haemost 14(3):461–467CrossRefPubMed
2.
Zurück zum Zitat Brodsky SV, Hebert LA (2016) Anticoagulant-related nephropathy: is an AKI elephant hiding in plain view? J Am Coll Cardiol 68(21):2284–2286CrossRefPubMed Brodsky SV, Hebert LA (2016) Anticoagulant-related nephropathy: is an AKI elephant hiding in plain view? J Am Coll Cardiol 68(21):2284–2286CrossRefPubMed
3.
Zurück zum Zitat Brodsky SV, Satoskar A, Chen J, Nadasdy G, Eagen JW, Hamirani M, Hebert L, Calomeni E, Nadasdy T (2009) Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 54(6):1121–1126CrossRefPubMed Brodsky SV, Satoskar A, Chen J, Nadasdy G, Eagen JW, Hamirani M, Hebert L, Calomeni E, Nadasdy T (2009) Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 54(6):1121–1126CrossRefPubMed
4.
Zurück zum Zitat Brodsky SV, Nadasdy T, Rovin BH, Satoskar AA, Nadasdy GM, Wu HM, Bhatt UY, Hebert LA (2011) Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 80(2):181–189CrossRefPubMedPubMedCentral Brodsky SV, Nadasdy T, Rovin BH, Satoskar AA, Nadasdy GM, Wu HM, Bhatt UY, Hebert LA (2011) Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 80(2):181–189CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Woo KT, Lee GS, Foo MW, Chan CM (2012) Warfarin-related nephropathy in patients with chronic kidney disease. Kidney Int 82:113 (author reply 113–114)CrossRefPubMed Woo KT, Lee GS, Foo MW, Chan CM (2012) Warfarin-related nephropathy in patients with chronic kidney disease. Kidney Int 82:113 (author reply 113–114)CrossRefPubMed
6.
Zurück zum Zitat Ware K, Brodsky P, Satoskar AA, Nadasdy T, Nadasdy G, Wu H, Rovin BH, Bhatt U, Von Visger J, Hebert LA, Brodsky SV (2011) Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol 22(10):1856–1862CrossRefPubMedPubMedCentral Ware K, Brodsky P, Satoskar AA, Nadasdy T, Nadasdy G, Wu H, Rovin BH, Bhatt U, Von Visger J, Hebert LA, Brodsky SV (2011) Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol 22(10):1856–1862CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ozcan A, Ware K, Calomeni E, Nadasdy T, Forbes R, Satoskar AA, Nadasdy G, Rovin BH, Hebert LA, Brodsky SV (2012) 5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol 35(4):356–364CrossRefPubMedPubMedCentral Ozcan A, Ware K, Calomeni E, Nadasdy T, Forbes R, Satoskar AA, Nadasdy G, Rovin BH, Hebert LA, Brodsky SV (2012) 5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol 35(4):356–364CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Ware K, Qamri Z, Ozcan A, Satoskar AA, Nadasdy G, Rovin BH, Hebert LA, Nadasdy T, Brodsky SV (2013) N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy. Am J Nephrol 35(4):356–364 Ware K, Qamri Z, Ozcan A, Satoskar AA, Nadasdy G, Rovin BH, Hebert LA, Nadasdy T, Brodsky SV (2013) N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy. Am J Nephrol 35(4):356–364
9.
Zurück zum Zitat Ryan M, Ware K, Qamri Z, Satoskar A, Wu H, Nadasdy G, Rovin B, Hebert L, Nadasdy T, Brodsky SV (2014) Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats. Nephrol Dial Transplant 29(12):2228–2234CrossRefPubMed Ryan M, Ware K, Qamri Z, Satoskar A, Wu H, Nadasdy G, Rovin B, Hebert L, Nadasdy T, Brodsky SV (2014) Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats. Nephrol Dial Transplant 29(12):2228–2234CrossRefPubMed
10.
Zurück zum Zitat Berger R, Salhanick SD, Chase M, Ganetsky M (2013) Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin. Ann Emerg Med 61(4):475–479CrossRefPubMed Berger R, Salhanick SD, Chase M, Ganetsky M (2013) Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin. Ann Emerg Med 61(4):475–479CrossRefPubMed
11.
Zurück zum Zitat Rizk D, Warnock D (2011) Warfarin-related nephropathy: another newly recognized complication of an old drug. Kidney Int 80(2):131–133CrossRefPubMed Rizk D, Warnock D (2011) Warfarin-related nephropathy: another newly recognized complication of an old drug. Kidney Int 80(2):131–133CrossRefPubMed
12.
Zurück zum Zitat Brodsky SV, Collins M, Park E, Rovin BH, Satoskar AA, Nadasdy G, Wu H, Bhatt U, Nadasdy T, Hebert LA (2010) Warfarin therapy that results in an international normalization ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract 115(2):c142–c146CrossRefPubMedPubMedCentral Brodsky SV, Collins M, Park E, Rovin BH, Satoskar AA, Nadasdy G, Wu H, Bhatt U, Nadasdy T, Hebert LA (2010) Warfarin therapy that results in an international normalization ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract 115(2):c142–c146CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat An JN, Ahn SY, Yoon CH, Youn TJ, Han MK, Kim S, Chin HJ, Na KY, Chae DW (2013) The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in Korean patients. PLoS ONE 8(4):e57661CrossRefPubMedPubMedCentral An JN, Ahn SY, Yoon CH, Youn TJ, Han MK, Kim S, Chin HJ, Na KY, Chae DW (2013) The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in Korean patients. PLoS ONE 8(4):e57661CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Lim AK, Campbell DA (2013) Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation. Int Urol Nephrol 45(2):561–570CrossRefPubMed Lim AK, Campbell DA (2013) Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation. Int Urol Nephrol 45(2):561–570CrossRefPubMed
Metadaten
Titel
Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study
verfasst von
Siavash Piran
Hugh Traquair
Noel Chan
Marlene Robinson
Sam Schulman
Publikationsdatum
03.02.2018
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 4/2018
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1626-1

Weitere Artikel der Ausgabe 4/2018

Journal of Thrombosis and Thrombolysis 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.